[HTML][HTML] Effects of palmitoylethanolamide (PEA) on nociceptive, musculoskeletal and neuropathic pain: Systematic review and meta-analysis of clinical evidence

D Scuteri, F Guida, S Boccella, E Palazzo, S Maione… - Pharmaceutics, 2022 - mdpi.com
Some 30–50% of the global population and almost 20% of the European population actually
suffer from chronic pain, which presents a tremendous burden to society when this pain …

[HTML][HTML] Therapeutic efficacy of palmitoylethanolamide and its new formulations in synergy with different antioxidant molecules present in diets

AF Peritore, R Siracusa, R Crupi, S Cuzzocrea - Nutrients, 2019 - mdpi.com
The use of a complete nutritional approach seems increasingly promising to combat chronic
inflammation. The choice of healthy sources of carbohydrates, fats, and proteins, associated …

Palmitoylethanolamide dampens reactive astrogliosis and improves neuronal trophic support in a triple transgenic model of Alzheimer's disease: in vitro and in vivo …

MR Bronzuoli, R Facchinetti… - Oxidative medicine …, 2018 - Wiley Online Library
Alzheimer's disease (AD) is a neurodegenerative disorder responsible for the majority of
dementia cases in elderly people. It is widely accepted that the main hallmarks of AD are not …

Palmitoylethanolamide is a new possible pharmacological treatment for the inflammation associated with trauma

E Esposito, S Cuzzocrea - Mini reviews in medicinal chemistry, 2013 - ingentaconnect.com
The endogenous fatty acid palmitoylethanolamide (PEA) is one of the members of N-acyl-
ethanolamines family. PEA was identified more than five decades ago and was shown to …

[HTML][HTML] Palmitoylethanolamide protects against the amyloid-β25-35-induced learning and memory impairment in mice, an experimental model of Alzheimer disease

G D'agostino, R Russo, C Avagliano… - …, 2012 - nature.com
Alzheimer disease (AD) is the most common form of neurodegenerative dementia. Amyloid-
β deposition, neurofibrillary tangle formation, and neuro-inflammation are the major …

Central administration of palmitoylethanolamide reduces hyperalgesia in mice via inhibition of NF-κB nuclear signalling in dorsal root ganglia

G D'Agostino, G La Rana, R Russo, O Sasso… - European journal of …, 2009 - Elsevier
Despite the clear roles played by peroxisome proliferators-activated receptor α (PPAR-α) in
lipid metabolism, inflammation and feeding, the effects of its activation in the central nervous …

[HTML][HTML] Palmitoylethanolamide dampens neuroinflammation and anxiety-like behavior in obese mice

A Lama, C Pirozzi, I Severi, MG Morgese… - Brain, behavior, and …, 2022 - Elsevier
High-fat diet (HFD) consumption leads to obesity and a chronic state of low-grade
inflammation, named metainflammation. Notably, metainflammation contributes to …

Microglia produce and hydrolyze palmitoylethanolamide

GG Muccioli, N Stella - Neuropharmacology, 2008 - Elsevier
Microglial cell activation and migration play an important role in neuroinflammation
propagation. While it is known that the lipid transmitter palmitoylethanolamide (PEA) …

Palmitoylethanolamide, a naturally occurring disease-modifying agent in neuropathic pain

SD Skaper, L Facci, M Fusco, MF Della Valle… - …, 2014 - Springer
Persistent pain affects nearly half of all people seeking medical care in the US alone, and
accounts for at least $80 billion worth of lost productivity each year. Among all types of …

Endogenous fatty acid ethanolamides suppress nicotine-induced activation of mesolimbic dopamine neurons through nuclear receptors

M Melis, G Pillolla, A Luchicchi, AL Muntoni… - Journal of …, 2008 - Soc Neuroscience
Nicotine stimulates the activity of mesolimbic dopamine neurons, which is believed to
mediate the rewarding and addictive properties of tobacco use. Accumulating evidence …